Regulus: Q2 Earnings Snapshot

August 11, 2022 GMT

SAN DIEGO (AP) _ Regulus Therapeutics Inc. (RGLS) on Thursday reported a loss of $7.3 million in its second quarter.

On a per-share basis, the San Diego-based company said it had a loss of 50 cents.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RGLS at https://www.zacks.com/ap/RGLS